Hunan Jingfeng Pharmaceutical Co.,Ltd.

Symbol: 000908.SZ

SHZ

2.07

CNY

Markedspris i dag

-6.8734
P/E-forhold
-0.0686
PEG Ratio
1.82B
MRK Cap
0.00%
DIV Udbytte

Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908-SZ) Årsregnskaber

Q: Hvad er virksomhedens profitmargin?

Virksomhedens profitmargin er .

Download

Årlig Kvartalsvis

Lineær Log

På diagrammet kan du se standardtallene i dynamik for Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ). Virksomhedens omsætning viser gennemsnittet af NaN M, som er NaN % gowth. Den gennemsnitlige bruttofortjeneste for hele perioden er NaN M, som er NaN %. Den gennemsnitlige bruttofortjeneste er NaN %. Væksten i nettoindkomst for virksomheden sidste år er NaN %, hvilket svarer til NaN % % i gennemsnit for hele virksomhedens historie.,

Årlig Kvartalsvis

10Y 20Y 30Y 40Y

Balance

Når vi dykker ned i den skattemæssige udvikling for Hunan Jingfeng Pharmaceutical Co.,Ltd., ser vi en gennemsnitlig aktivvækst. Det er interessant, at denne rate ligger på , hvilket afspejler både virksomhedens op- og nedture. Når man sammenligner kvartal for kvartal, justeres dette tal til . Et kig tilbage på det seneste år afslører en samlet aktivændring på NaN. Aktionærværdi, som vist ved den samlede egenkapital, er vurderet til NaN i rapporteringsvalutaen. Ændringen fra år til år i dette aspekt er NaN%.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996
balance-sheet.row.cash-and-short-term-investments	13.2	181.4	172.2	164.2	405.5	512.1	472.1	1201.9	519.7	214.5	33.4	18.6	16.6	47.3	32.8	53.3	93.9	15.4	65.5	154.1	302	266	174.2	210.5	334.4	291.2	7.9	16.4	6.1
balance-sheet.row.short-term-investments	0	0	-7.4	-103.6	-137.8	343.6	-81.5	-30.5	0	0	0	0	0	0	2.4	-67	0.8	0.3	29.7	54.8	165.3	1.6	0	60	60	50	0	0	0
balance-sheet.row.net-receivables	85.9	233.2	301.3	575.9	877.9	1786.3	1828.1	1742.8	1251	866.6	99.9	108.8	162.9	195.6	205.2	248.2	379.6	261.2	591.2	603.2	324.8	183.4	146.4	53.5	11.1	71.8	47.5	43.8	13.1
balance-sheet.row.inventory	64.6	120.4	155.4	232.4	326.3	268.9	276.1	236.2	160.9	128.6	33.2	41.3	38.5	35.5	31	102.6	71.2	95.6	98.8	90.7	77.9	113.3	92.7	59.8	38.7	19.1	18.6	25.4	17.3
balance-sheet.row.other-current-assets	14.9	36.4	48.7	49.4	173.9	23.1	5.2	16.8	1.9	-138.6	-6.1	-10.3	-15.6	-30.9	-36.6	-44.7	-120.1	0	-221.4	-216.8	0	-27.8	-20.5	130.6	107.1	-21.7	-8.6	-11.4	-2.8
balance-sheet.row.total-current-assets	213.8	571.3	677.5	1021.9	1783.6	2590.4	2581.6	3197.8	1933.6	1071.2	160.5	158.4	202.4	247.6	232.3	359.3	424.5	372.2	534.1	631.2	704.7	534.9	392.8	454.4	491.3	360.5	65.4	74.3	33.6
balance-sheet.row.property-plant-equipment-net	434.2	566.4	726.1	1013.8	1232	1049.2	785	667.7	483.9	347.4	83.7	104.2	109.2	104.4	122.5	131	115.7	174.6	180.2	146.3	155	189.2	158.4	115.1	81.7	65	38.6	40.9	24.7
balance-sheet.row.goodwill	0.1	33	33	72	432.7	737.4	705.8	705.8	688.3	355.9	208.6	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	168.2	204.4	210.4	244.8	365.2	348.2	248.5	162.4	70.9	29.6	43.8	58.6	58.6	45.5	321.1	356.1	83.3	105.4	92.2	91.8	103.1	109.1	41.4	49.1	43.8	24	11	4.4	3.1
balance-sheet.row.goodwill-and-intangible-assets	168.3	237.4	243.5	316.8	797.9	1085.6	954.3	868.2	759.2	385.5	43.8	58.6	58.6	45.5	321.1	356.1	83.7	105.4	92.2	91.8	103.1	109.1	41.4	49.1	43.8	24	11	4.4	3.1
balance-sheet.row.long-term-investments	44.7	50.5	111.3	270.4	456.5	0	421.8	251.1	0	0	0	0	0	0	46.3	121.6	114.6	169.3	3.3	-35.2	-146.4	29.7	0	-34.9	-37.3	-26.6	0	0	0
balance-sheet.row.tax-assets	10.4	27.9	23.6	64.3	57.2	48	17.1	19.2	20.5	13.6	0	0	0	0.8	1	7.2	7.1	0	0	0	0	0	0	61.1	60.3	50	0	0	0
balance-sheet.row.other-non-current-assets	188.9	15	10.4	2.9	22.9	453.9	109	130	245.4	96.1	48.8	48.8	51.3	73.1	61.5	14	68.7	0.9	30.4	55.4	166.6	3.8	28.2	53.1	52.1	0.3	17.2	12	4.8
balance-sheet.row.total-non-current-assets	846.6	897.2	1114.8	1668.1	2566.4	2636.7	2287.2	1936.3	1509.1	842.6	176.3	211.7	219	223.8	552.5	629.9	389.9	450.2	306	258.4	278.3	331.7	228	243.5	200.6	112.7	66.8	57.2	32.7
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	1060.3	1468.5	1792.3	2690	4350.1	5227.1	4868.8	5134	3442.6	1913.8	336.8	370.1	421.4	471.4	784.8	989.2	814.4	822.5	840.1	889.6	983	866.7	620.9	697.9	691.9	473.2	132.2	131.5	66.3
balance-sheet.row.account-payables	148.9	138.5	123	186.2	187.1	194.8	114.2	111	134.5	86.7	58.2	61.4	46.4	50	45.6	49.9	53.3	54	62.8	110.1	181.9	79.2	46.5	34.6	16.4	11.2	9.6	7.6	5.4
balance-sheet.row.short-term-debt	498.9	516.5	864.6	1423.1	1306.5	895.3	621.2	809.4	516.5	480	233.6	296.1	327.8	219	226	367	405.4	358.7	377.1	369.6	340.6	225.1	37.6	81.9	125.3	5	1.1	9	4.4
balance-sheet.row.tax-payables	24.4	47	24.8	7.6	8.9	106.7	109.8	152.4	114.1	61.3	-18.4	-20	-21.3	-24.3	-27.8	-35.4	-19.5	-10.3	-16.2	-21.2	-12.5	-5.3	-2.3	8	8.6	7	1.5	0.5	-0.4
balance-sheet.row.long-term-debt-total	95	82.4	8.9	37.8	389	874.3	1182.8	1169.9	160.8	56	-74.7	0	0	114.8	144.8	192.1	0	0	0	10	0	10	24.4	42.7	40.2	27.2	19.3	11	10
Deferred Revenue Non Current	20.7	24.8	51	124.2	173.2	61.6	37.2	38.8	39.7	39	29.7	0	0	-114.8	192.1	0	0	0	0	0	0	0	0	-42.7	-40.2	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	10.7	402.2	2.3	2.8	49.2	186.3	53.6	32.6	24.9	10.5	3.7	8.6	3.9	4.7	16.1	12.6	5.7	7.9	11.3	35.6	29.6	19.3	7	6.7	4.9	3	2.7	3.7	2.9
balance-sheet.row.total-non-current-liabilities	172.5	170.3	103.5	193.2	739.9	981.9	1221.4	1229	224.6	121.9	3.9	4	5.4	119.1	352.2	200.3	6.3	0	0	17	6	10	24.4	46.8	45.7	34.2	19.3	11	10
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	22.7	9.8	7.9	45.6	152.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	1214	1253.6	1464.6	2051.8	2408.3	2365	2268.9	2521.6	1194.2	919.8	331.5	430.3	420.7	413.5	684.1	650.6	477.4	486.1	510.5	550.1	563.6	344	122.5	197.4	206.5	72.5	45.7	70.7	35.5
balance-sheet.row.preferred-stock	112	0	0	135.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	416.7	416.7	416.7	416.7	416.7	416.7	416.7	416.7	336.7	275.4	280	280	280	280	280	280	280	280	280	280	280	280	280	280	140	140	0	0	0
balance-sheet.row.retained-earnings	-1177.3	-949	-820.9	-657.2	413.4	1296.2	1122.8	982.9	739	466.6	-472.4	-475.7	-414.9	-358	-361	-122.5	-89	-91.9	-94.6	-97.6	-21.3	89.8	77.9	75.3	73.7	28.1	3.8	0	0
balance-sheet.row.accumulated-other-comprehensive-income-loss	-18.6	710.3	710.6	-135.5	757.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	617.8	0	0	760.5	0	770.7	839	992.6	1097.9	239.2	197.3	135.3	135.3	135.3	134.6	134.2	142.8	146.7	142.8	142.6	141.9	141.4	139.6	135.4	240.5	232.5	82.8	0	0
balance-sheet.row.total-stockholders-equity	-49.5	177.9	306.4	520	1588	2483.7	2378.5	2392.2	2173.7	981.2	4.9	-60.5	0.3	57.3	53.7	291.7	333.8	334.8	328.2	325	400.5	511.2	497.5	490.7	454.3	400.6	86.5	60.8	30.8
balance-sheet.row.total-liabilities-and-stockholders-equity	1060.3	1468.5	1792.3	2690	4350.1	5227.1	4868.8	5134	3442.6	1913.8	336.8	370.1	421.4	471.4	784.8	989.2	814.4	822.5	840.1	889.6	983	866.7	620.9	697.9	691.9	473.2	132.2	131.5	66.3
balance-sheet.row.minority-interest	-104.2	36.9	21.3	118.1	353.8	378.4	221.4	220.2	74.8	12.8	0.4	0.3	0.5	0.6	47	47	3.1	1.6	1.5	14.5	18.8	11.5	0.9	9.8	31.1	0	0	0	0
balance-sheet.row.total-equity	-153.7	214.8	327.7	638.2	1941.8	2862.1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	44.7	50.5	103.9	166.8	318.8	343.6	340.3	220.6	235.9	86.4	45.6	45.7	48.6	48.6	48.7	54.6	115.4	169.7	32.9	19.7	18.8	31.3	25.7	25.1	22.7	23.4	16.7	11.2	3.8
balance-sheet.row.total-debt	593.9	598.8	873.5	1423.1	1695.5	1769.6	1804	1979.2	677.3	536	233.6	296.1	327.8	333.8	370.8	367	405.4	358.7	377.1	379.6	340.6	235.1	62.1	124.6	165.5	32.2	20.5	20	14.4
balance-sheet.row.net-debt	580.7	417.4	701.3	1258.9	1290	1257.5	1331.9	777.3	157.5	321.5	200.1	277.5	311.2	286.5	340.4	313.7	312.3	343.6	341.2	280.3	203.8	-29.4	-112.2	-25.9	-109	-209.1	12.5	3.6	8.3

Pengestrømsopgørelse

Det økonomiske landskab for Hunan Jingfeng Pharmaceutical Co.,Ltd. har set en bemærkelsesværdig ændring i det frie cash flow i løbet af den sidste periode, hvilket udviser et skift på NaN. Virksomheden udvidede for nylig sin aktiekapital ved at udstede NaN, hvilket markerer en forskel på NaN i forhold til det foregående år. Virksomhedens investeringsaktiviteter resulterede i et nettokasseforbrug på NaN i rapporteringsvalutaen. Dette er en forskydning på NaN fra året før. I samme periode har virksomheden registreret NaN, NaN og NaN, som er væsentlige for forståelsen af virksomhedens investerings- og afdragsstrategier. Virksomhedens finansieringsaktiviteter førte til et nettokasseforbrug på NaN, med en forskel fra år til år på NaN. Desuden afsatte virksomheden NaN til udbetaling af udbytte til sine aktionærer. Samtidig foretog virksomheden andre finansielle manøvrer, kaldet NaN, som også påvirkede pengestrømmen betydeligt i denne periode. Disse komponenter tegner tilsammen et omfattende billede af virksomhedens økonomiske status og strategiske tilgang til likviditetsstyring.

common:word.in-mln USD Growth	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003	2001	1999
cash-flows.row.net-income	-100.9	-201.6	-1047.7	-921.6	198.5	185.2	388.1	370.2	257.4	3.4	-60.9	-57.1	2.9	-244	-31.9	5.8	2.7	3	-65.3	14.7	14.4	11.9	46.3	56.8	29.3
cash-flows.row.depreciation-and-amortization	55.4	107.5	81.5	76.4	92.6	73.4	60.4	41.7	27.5	8.3	8.8	9.1	9.8	19.1	15.7	11.1	11.9	10.7	10.4	12.5	9.9	6.9	5.6	4.4	0
cash-flows.row.deferred-income-tax	0	0	-6.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	0	0	6.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	72.5	321.9	158.5	498.9	-53.1	-222.5	-517.7	-384.8	-118.4	-5.9	15.2	20.2	-59.2	43.3	27.7	38.8	13.4	-95.6	-159.4	-19	-13.1	20.1	-70.3	-32.2	0
cash-flows.row.account-receivables	54.9	254.9	274	449.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	37.3	69.4	82.4	-58.7	7.9	-39.9	9.8	-9.1	-10.4	6.5	-7.2	-4.2	-4.6	49.9	-32.2	24.4	3.3	-24.1	-16.1	-21.5	-16	-32.9	-21.1	-17.6	0
cash-flows.row.account-payables	-54.9	-254.9	-191.9	-449.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	35.2	252.6	-5.9	557.6	-61	-182.7	-527.5	-375.7	-108	-12.4	22.4	24.4	-54.6	-6.6	60	14.4	10.2	-71.5	-143.3	2.5	2.8	53	-49.2	-14.5	0
cash-flows.row.other-non-cash-items	96.2	-103.9	536	382.4	112.9	115.5	81.5	65.2	39.4	-9.3	37.3	20.9	31.2	169.7	19.6	-3.4	29.8	22.4	57.8	14.3	6.4	-8.3	-6.6	-15.4	-29.3
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-13.5	-38.1	-96	-113.6	-171.1	-303.2	-252.8	-223.2	-100.6	-1.7	-5.2	-4.8	-3.9	-11.8	-26.9	-0.6	-0.6	-1.3	-5.5	-15.2	-99.8	-41.5	-45.6	-18.3	-4.1
cash-flows.row.acquisitions-net	63.6	253.4	434.2	135.6	-10.1	-317.3	-243.3	-532.7	-321.1	0.7	0	10.1	42.2	12.3	0.1	0.1	1.8	1.3	10.7	2	0	41.5	0.2	0.2	0
cash-flows.row.purchases-of-investments	0	0	-250	-322	-120	303.3	-106	0	0	0	-0.8	0	-0.3	-8.8	-14.2	-31.3	-34.8	-6	-37.3	-0.1	-7	-6.9	-122.4	-112	-50.4
cash-flows.row.sales-maturities-of-investments	53.3	45.4	352.6	231.8	100.6	15.4	102	10.2	0	0	0	0	30.3	14.1	35.8	1.5	3.2	8.2	139	7	5.6	122.1	137.1	58.6	0
cash-flows.row.other-investing-activites	118.3	12	2	17.4	0.8	-303.2	24	9.3	-15.3	5.2	36.8	0.1	0	-11.8	0.5	1.5	-0.6	-1.3	3.7	-4.2	0.1	-41.5	-24.9	-38.7	0.1
cash-flows.row.net-cash-used-for-investing-activites	221.7	272.7	442.7	-50.8	-199.7	-605.1	-476.2	-736.4	-437	4.2	30.8	5.3	68.3	-5.9	-4.7	-28.7	-31	0.9	110.5	-10.4	-101.1	73.7	-55.5	-110.2	-54.5
cash-flows.row.debt-repayment	-454.2	-585.3	-1214.9	-1252.4	-820.2	-918.8	-803.5	-588.2	-236.3	-131.9	-36.7	-6	-214.9	-61	-188.8	-256.1	-292.2	-205.1	-325	-232.5	-112.6	-136.3	-135.9	-22	-0.6
cash-flows.row.common-stock-issued	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-39.6	-91.5	-89.2	-86.6	-102.1	-91.4	-132.2	-51.8	-28.7	-53	0	-3.8	-8.1	-16.5	-19.9	-23.4	-29.9	-23.3	-31.1	-16.4	-9.1	-17.2	-8.6	-2.8	-3.2
cash-flows.row.other-financing-activites	157.7	289.5	889.4	1245	809.8	735.3	2080.1	1589.2	564.9	193.9	5	0	173.9	64.8	142.6	334	274.5	226.1	364.5	186.5	295.4	73.8	101.2	154.6	265.2
cash-flows.row.net-cash-used-provided-by-financing-activities	-336.2	-387.3	-414.7	-94	-112.6	-274.9	1144.4	949.3	299.8	9	-31.7	-9.8	-49.1	-12.7	-66.1	54.5	-47.6	-2.3	8.4	-62.4	173.7	-79.7	-43.4	129.7	261.4
cash-flows.row.effect-of-forex-changes-on-cash	0.2	-0.1	-2	2	1.3	-1.4	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	9	9.2	-245.7	-106.6	40	-729.8	682.2	305.2	68.8	9.8	-0.6	-11.4	4	-30.5	-39.8	78	-20.7	-60.9	-37.5	-50.3	90.2	24.5	-123.9	33.2	206.9
cash-flows.row.cash-at-end-of-period	177.9	168.9	159.8	405.5	512.1	472.1	1201.9	519.7	214.5	24.6	14.8	15.4	26.8	22.8	53.3	93.1	15.1	35.8	99.3	214.1	264.4	174.2	150.5	274.4	206.9
cash-flows.row.cash-at-beginning-of-period	168.9	159.8	405.5	512.1	472.1	1201.9	519.7	214.5	145.7	14.8	15.4	26.8	22.8	53.3	93.1	15.1	35.8	96.8	136.7	264.4	174.2	149.7	274.4	241.3	0
cash-flows.row.operating-cash-flow	123.3	123.8	-271.7	36.2	350.9	151.7	12.3	92.4	205.9	-3.4	0.4	-6.9	-15.2	-11.9	31	52.3	57.9	-59.5	-156.4	22.5	17.6	30.5	-25	13.6	0
cash-flows.row.capital-expenditure	-13.5	-38.1	-96	-113.6	-171.1	-303.2	-252.8	-223.2	-100.6	-1.7	-5.2	-4.8	-3.9	-11.8	-26.9	-0.6	-0.6	-1.3	-5.5	-15.2	-99.8	-41.5	-45.6	-18.3	-4.1
cash-flows.row.free-cash-flow	109.8	85.7	-367.7	-77.5	179.8	-151.6	-240.5	-130.8	105.3	-5.2	-4.8	-11.7	-19.1	-23.6	4.1	51.7	57.3	-60.8	-161.9	7.4	-82.2	-11	-70.7	-4.6	-4.1

Resultatopgørelse række

Hunan Jingfeng Pharmaceutical Co.,Ltd.s omsætning oplevede en ændring på NaN% sammenlignet med den foregående periode. Bruttofortjenesten for 000908.SZ rapporteres til at være NaN. Virksomhedens driftsomkostninger er NaN og viser en ændring på NaN% fra sidste år. Udgifterne til afskrivninger er NaN, hvilket er en ændring på NaN% fra sidste regnskabsperiode. Driftsudgifterne rapporteres at være NaN, hvilket viser en NaN% ændring fra år til år. Salgs- og marketingomkostninger er NaN, hvilket er en ændring på NaN% sammenlignet med året før. EBITDA baseret på de seneste tal er NaN, hvilket repræsenterer en NaN% vækst i forhold til året før. Driftsindtægterne er NaN, som viser en ændring på NaN% sammenlignet med året før. Ændringen i nettoindkomsten er NaN%. Nettoindkomsten for det sidste år var NaN.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996
income-statement-row.row.total-revenue	656.9	840.7	811.2	877.9	1344	2585.7	2583.7	2640.5	2459	1957.4	167.3	145.3	139	217.4	236.4	216.8	187.7	237.6	214.4	258.6	217.1	214.4	171.2	189.3	136	86.4	65.9	68.6	67.5
income-statement-row.row.cost-of-revenue	185.5	199.7	308	318.4	537.1	629.4	552.3	559.3	463.5	289.1	131.6	122	118.7	181.1	242.1	186.5	161.2	170.2	160.9	232.7	204.7	165.6	138	133.6	82.4	48	37	46.3	49.3
income-statement-row.row.gross-profit	471.4	641	503.2	559.5	807	1956.3	2031.3	2081.2	1995.5	1668.3	35.7	23.3	20.3	36.3	-5.7	30.3	26.5	67.4	53.5	25.9	12.4	48.8	33.2	55.7	53.6	38.4	28.9	22.3	18.2
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	22.1	107.3	129.4	142.2	168.5	-11.2	-8.3	30.7	18.1	13.1	2.1	0.9	18.4	27	-7.3	3.1	5.9	2	1.7	1.8	-8	5.7	4.1	6.5	2.3	1	1.6	2.2	0.8
income-statement-row.row.operating-expenses	548.8	624.1	761.4	1074	1362.2	1604.2	1678.8	1570.8	1524	1338.9	42.9	47.9	54.8	46.8	61.5	45.9	30.5	36.6	31.3	62.2	42.4	34.6	34.1	20.3	12.7	10.1	6.1	8.9	8.1
income-statement-row.row.cost-and-expenses	734.3	823.8	1069.4	1392.4	1899.3	2233.6	2231.2	2130.1	1987.5	1628	174.5	169.9	173.6	227.8	303.5	232.4	191.8	206.8	192.2	294.9	247.1	200.2	172.1	153.8	95.1	58.1	43.1	55.2	57.4
income-statement-row.row.interest-income	1.2	1.1	0.6	1.4	6.7	2.2	3.7	2.7	2.6	0.8	0.3	0.1	0.3	0.6	0.6	1.4	1.8	1.2	1.2	2.8	4.7	1.8	2.7	3.9	0	0	0	0	0
income-statement-row.row.interest-expense	39.9	52.4	86.1	106.2	105	84.6	93.5	68.4	49.8	28.5	6.1	20.4	19.8	19.9	30.9	28.9	24.7	29.9	21.8	23.2	16.3	9.3	7.4	8.6	-1.5	2.1	2.4	2.5	3
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-96.3	-105	-134	-637.4	-364.5	-108.4	-102.7	-39.8	-37.8	-23.4	10.5	-36.5	-21.8	13.5	-170.8	-16.6	8.8	-28.7	-19.3	-27.8	-21.5	-1.8	8.4	13.6	23.5	4.3	4.2	6	-2.1
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	22.1	107.3	129.4	142.2	168.5	-11.2	-8.3	30.7	18.1	13.1	2.1	0.9	18.4	27	-7.3	3.1	5.9	2	1.7	1.8	-8	5.7	4.1	6.5	2.3	1	1.6	2.2	0.8
income-statement-row.row.total-operating-expenses	-96.3	-105	-134	-637.4	-364.5	-108.4	-102.7	-39.8	-37.8	-23.4	10.5	-36.5	-21.8	13.5	-170.8	-16.6	8.8	-28.7	-19.3	-27.8	-21.5	-1.8	8.4	13.6	23.5	4.3	4.2	6	-2.1
income-statement-row.row.interest-expense	39.9	52.4	86.1	106.2	105	84.6	93.5	68.4	49.8	28.5	6.1	20.4	19.8	19.9	30.9	28.9	24.7	29.9	21.8	23.2	16.3	9.3	7.4	8.6	-1.5	2.1	2.4	2.5	3
income-statement-row.row.depreciation-and-amortization	44.5	55.4	107.5	276.4	138	92.6	73.4	60.4	41.7	27.5	8.3	8.8	9.1	9.8	19.1	15.7	11.1	11.9	10.7	10.4	12.5	9.9	6.9	5.6	4.4	-5	-4.9	-6.1	0.9
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-172.9	14.5	-21.5	-514.5	-555.3	254.9	258.1	440.9	415.8	293.6	2.5	-61.9	-55.2	-24	-230.6	-35	-1.1	1.6	2.7	-67.2	-50.9	16.3	12.2	52.8	64	33.3	27.7	19.5	9.2
income-statement-row.row.income-before-tax	-173.7	-90.6	-155.4	-1151.9	-919.8	243.8	249.8	470.6	433.7	306.1	3.3	-61.1	-56.4	3	-238	-32.1	4.8	2.9	3.7	-64.8	-50.2	17.2	11.9	54.1	65.3	33.4	28.1	20.5	9
income-statement-row.row.income-tax-expense	32.8	10.3	46.2	3.4	1.8	45.2	64.6	82.5	63.5	48.7	-0.1	-0.1	0.7	0.1	6.1	-0.2	-1	0.2	0.7	0.5	2.1	3.1	0.9	7.8	8.5	4.1	1.3	1.9	1
income-statement-row.row.net-income	-215.1	-100.9	-201.6	-1155.3	-921.6	186.8	162.1	340	324.1	251	3.4	-60.8	-57	3	-238.4	-33.5	5.7	2.7	3	-65.1	-52.8	14	12.2	46.2	56.8	29.3	26.9	18.7	8